TREATMENT OF COGNITIVE IMPAIRMENT
- 专利权人:
- Ovid Therapeutics Inc.
- 发明人:
- Matthew DURING
- 申请号:
- US15292660
- 公开号:
- US20170119704A1
- 申请日:
- 2016.10.13
- 申请国别(地区):
- US
- 年份:
- 2017
- 代理人:
- 摘要:
- Provided are methods of treating cognitive impairment and/or psychosis and/or movement disorders by administering a pharmaceutical composition of eplivanserin or a pharmaceutically acceptable salt thereof to a subject in need thereof.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
- Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
- COMBINATION OF BREXPIPRAZOLE AND NALMEFENE AND USE THEREOF FOR TREATING SUBSTANCE-RELATED DISORDERS
- Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
- Combination of Brexpiprazole and Nalmefene and Use Thereof for Treating Substance-Related Disorders